Proteomic Profiling and Neurodegeneration in Alzheimer's Disease

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2002 Dec 5

PMID 12462422

Citations 35

Authors

T Tsuji

A Shiozaki

R Kohno

K Yoshizato

S Shimohama

Affiliations

Soon will be listed here.

Abstract

Quantitative proteome analysis of Alzheimer's disease (AD) brains was performed using 2-D gels to identify disease specific changes in protein expression. The task of characterizing the proteome and its components is now practically achievable because of the development and integration of four important tools: protein, EST, and complete genome sequence databases, mass spectrometry, matching software for protein sequences and protein separation technology. Mass spectrometry (MS) instrumentation has undergone a tremendous change over the past decade, culminating in the development of highly sensitive, robust instruments that can reliably analyze biomolecules, particularly proteins and peptides; we identified 35 proteins from over 100 protein spots on a 2-D gel. Using this current technology, protein-expression profiling, which is actually a specialized form of mining, is an important principal application of proteomics. The information obtained has tremendous potential as a means of determining the pathogenesis, and detecting disease markers and potential targets for drug therapy in AD.

Citing Articles

Sorcin: mechanisms of action in cancer hallmarks, drug resistance and opportunities in therapeutics.

Ghosh S, Sharma A, Kumar R, Nasare V Med Oncol. 2024; 42(1):29.

PMID: 39673665 DOI: 10.1007/s12032-024-02580-6.

Sorcin in Cancer Development and Chemotherapeutic Drug Resistance.

Exertier C, Antonelli L, Fiorillo A, Bernardini R, Colotti B, Ilari A Cancers (Basel). 2024; 16(16).

PMID: 39199583 PMC: 11352664. DOI: 10.3390/cancers16162810.

Cultured Rat Hippocampal Neurons Exposed to the Mitochondrial Uncoupler Carbonyl Cyanide Chlorophenylhydrazone Undergo a Rapid, Presenilin-Dependent Change in Neuronal Properties.

Kushnireva L, Segal M, Korkotian E Int J Mol Sci. 2024; 25(1).

PMID: 38203751 PMC: 10779238. DOI: 10.3390/ijms25010578.

Genetically Encoded ATP Biosensors for Direct Monitoring of Cellular ATP Dynamics.

White 3rd D, Yang Q Cells. 2022; 11(12).

PMID: 35741049 PMC: 9221525. DOI: 10.3390/cells11121920.

ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer's Disease.

Patro S, Ratna S, Yamamoto H, Ebenezer A, Ferguson D, Kaur A Int J Mol Sci. 2021; 22(20).

PMID: 34681851 PMC: 8539681. DOI: 10.3390/ijms222011185.

References

Tsuji T, Shimohama S, Kamiya S, Sazuka T, Ohara O . Analysis of brain proteins in Alzheimer's disease using high-resolution two-dimensional gel electrophoresis. J Neurol Sci. 1999; 166(2):100-6. DOI: 10.1016/s0022-510x(99)00120-3. View

Maimone D, Dominici R, Grimaldi L . Pharmacogenomics of neurodegenerative diseases. Eur J Pharmacol. 2001; 413(1):11-29. DOI: 10.1016/s0014-2999(00)00939-0. View

Taylor J, Tinklenberg J, Eng L, Yesavage J, Vinogradov S, Davies H . Association study between Alzheimer's disease and restriction fragment length polymorphisms at the human amyloid beta protein gene locus. Mol Biol Med. 1988; 5(3):167-72. View

Wilm M, Shevchenko A, Houthaeve T, Breit S, Schweigerer L, Fotsis T . Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature. 1996; 379(6564):466-9. DOI: 10.1038/379466a0. View

Rabilloud T . Solubilization of proteins for electrophoretic analyses. Electrophoresis. 1996; 17(5):813-29. DOI: 10.1002/elps.1150170503. View

Mattson M, Gary D, Chan S, Duan W . Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease. Biochem Soc Symp. 2001; (67):151-62. DOI: 10.1042/bss0670151. View

Kidd P . Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Altern Med Rev. 2000; 5(5):402-28. View

Anderson N, Taylor J, Scandora A, Coulter B, Anderson N . The TYCHO system for computer analysis of two-dimensional gel electrophoresis patterns. Clin Chem. 1981; 27(11):1807-20. View

Gauss C, Kalkum M, Lowe M, Lehrach H, Klose J . Analysis of the mouse proteome. (I) Brain proteins: separation by two-dimensional electrophoresis and identification by mass spectrometry and genetic variation. Electrophoresis. 1999; 20(3):575-600. DOI: 10.1002/(SICI)1522-2683(19990301)20:3<575::AID-ELPS575>3.0.CO;2-3. View

10.

Edgar P, Schonberger S, Dean B, Faull R, Kydd R, Cooper G . A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol Psychiatry. 1999; 4(2):173-8. DOI: 10.1038/sj.mp.4000463. View

11.

Shevchenko A, Wilm M, Vorm O, Mann M . Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1996; 68(5):850-8. DOI: 10.1021/ac950914h. View

12.

Schonberger S, Edgar P, Kydd R, Faull R, Cooper G . Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics. 2001; 1(12):1519-28. DOI: 10.1002/1615-9861(200111)1:12<1519::aid-prot1519>3.0.co;2-l. View

13.

Blum D, Torch S, Lambeng N, Nissou M, Benabid A, Sadoul R . Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol. 2001; 65(2):135-72. DOI: 10.1016/s0301-0082(01)00003-x. View

14.

James P, Quadroni M, Carafoli E, Gonnet G . Protein identification by mass profile fingerprinting. Biochem Biophys Res Commun. 1993; 195(1):58-64. DOI: 10.1006/bbrc.1993.2009. View

15.

Rohlff C . Proteomics in molecular medicine: applications in central nervous systems disorders. Electrophoresis. 2000; 21(6):1227-34. DOI: 10.1002/(SICI)1522-2683(20000401)21:6<1227::AID-ELPS1227>3.0.CO;2-L. View

16.

Adessi C, Miege C, Albrieux C, Rabilloud T . Two-dimensional electrophoresis of membrane proteins: a current challenge for immobilized pH gradients. Electrophoresis. 1997; 18(1):127-35. DOI: 10.1002/elps.1150180124. View

17.

Shevchenko A, Wilm M, Mann M . Peptide sequencing by mass spectrometry for homology searches and cloning of genes. J Protein Chem. 1997; 16(5):481-90. DOI: 10.1023/a:1026361427575. View

18.

Paschen W, Frandsen A . Endoplasmic reticulum dysfunction--a common denominator for cell injury in acute and degenerative diseases of the brain?. J Neurochem. 2001; 79(4):719-25. DOI: 10.1046/j.1471-4159.2001.00623.x. View

19.

Morris H, Paxton T, Panico M, McDowell R, Dell A . A novel geometry mass spectrometer, the Q-TOF, for low-femtomole/attomole-range biopolymer sequencing. J Protein Chem. 1997; 16(5):469-79. DOI: 10.1023/a:1026309410737. View

20.

Tilleman K, Stevens I, Spittaels K, Van den Haute C, Clerens S, Van den Bergh G . Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view. Proteomics. 2002; 2(1):94-104. View